Global employers are ramping up investment in preventative healthcare as medical inflation continues to outpace broader economic trends, creating renewed pressure on insurers and reshaping the group health market.
According to Howden Employee Benefits' latest global study, 67% of employers are now directing resources toward prevention and wellbeing initiatives in an effort to curb rising claims and manage long-term benefit costs.
A sharper focus
The pressure point is clear. Howden projects global medical inflation to reach 7% in 2026 on a net-of-CPI basis, pushing total cost inflation for health plans well into double digits. With 93% of employers expecting their medical expenses to climb further -- and more than four in 10 anticipating a significant increase — the insurance industry is facing a sharper focus on pricing adequacy, claims trend forecasting and the sustainability of group health products, according to the study.
Insurers supplying corporate medical benefits are likely to see continued demand for prevention-led plan designs, including early-intervention programs, digital health tools and condition-management services. Howden’s data showed strong regional uptake, with prevention investment highest in Europe (74%), the UK (72%) and Latin America (71%). These trends point to a shift in insurer expectations where prevention is no longer a value-add but a core component of cost containment and a driver of future underwriting strategy.
A sensitive market
The insurance implications also extend beyond pricing. While 86% of employers believe they are securing strong value from their private healthcare plans, only 25% of employees share full confidence in employer-provided wellbeing support. This perception gap is prompting organisations to reassess coverage quality, which is already having a measurable effect on insurer–client relationships. Nearly a quarter of employers have switched health insurers in pursuit of better value, and another 39% plan to do so.
For insurers, this signals a market increasingly sensitive to service delivery, plan performance and transparency around ROI. Carriers unable to demonstrate measurable cost control or employee-level impact risk losing business to competitors offering more integrated or outcomes-based health solutions.
Regional disparities in cost expectations also carry underwriting implications. Employers in IMEA anticipate medical cost increases of 58%, compared with 27% in Europe and 28% in the UK. These uneven pressures could drive divergent pricing strategies, varying investment in digital health capabilities, and more localised product development across major global markets.
As healthcare becomes a key factor in employee retention and recruitment, insurers are positioned to play a central role in employers’ workforce strategies. But the widening gap between employer confidence and employee sentiment highlights an emerging challenge: insurers will be expected to provide not only financial protection but also measurable, demonstrable improvements in workforce health outcomes, making prevention-focused benefits a critical part of future growth.
